Ming Chen

ORCID: 0000-0003-2903-707X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmacological Effects of Natural Compounds
  • Research on Leishmaniasis Studies
  • Adipokines, Inflammation, and Metabolic Diseases
  • Pesticide and Herbicide Environmental Studies
  • Pharmacogenetics and Drug Metabolism
  • Diabetes and associated disorders
  • Glycosylation and Glycoproteins Research
  • Analytical Chemistry and Chromatography
  • Bioactive Compounds and Antitumor Agents
  • Medicinal Plants and Bioactive Compounds
  • Genomics, phytochemicals, and oxidative stress
  • Vitamin C and Antioxidants Research

Anhui University of Traditional Chinese Medicine
2022

The Affiliated Yongchuan Hospital of Chongqing Medical University
2021

Chongqing Medical University
2021

South China Normal University
2020

Statens Serum Institut
1995

Heart failure (HF) is a serious disease with high mortality. Oxidative stress plays vital role in its occurrence and development. Licorice commonly used to treat HF traditional Chinese medicine. Liquiritin, the main ingredient of licorice, has antioxidant anti-inflammatory properties, but mechanism against oxidative cardiomyocytes not been reported. Establishment damage model H9c2 cells by hydrogen peroxide (H2 O2 ). Liquiritin (5, 10, 20 μmol/L) could significantly prevent loss cell...

10.1111/jfbc.14351 article EN Journal of Food Biochemistry 2022-08-05

Kaempferide (Ka), a major natural active component of Tagetes erecta L, has numerous pharmacological effects such as anti-obesity, anticancer, and anti-hypertension. However, there is no clear evidence that Ka directly related to inflammation oxidative stress in obese mice. We aimed explore the on its mechanism.The mice were induced by high-fat diet (HFD). The anti-obesity effect was tested liver body weight, adiposity index, white adipose tissue. Blood sample analysis used detect...

10.22038/ijbms.2021.52690.11892 article EN DOAJ (DOAJ: Directory of Open Access Journals) 2021-04-01
Coming Soon ...